Pablo Garcia
LightNews LightNews
pablogarciamd.bsky.social
Pablo Garcia
@pablogarciamd.bsky.social
650 followers 530 following 12 posts
Academic Transplant and General Nephrologist - University of New Mexico
Posts Replies Media Videos
pablogarciamd.bsky.social
My understanding is that Renasight is not available in Latin America, I might be wrong. It will be better to get it done in the US
November 11, 2025 at 10:03 PM
pablogarciamd.bsky.social
Is this considered a simultaneous publication?

Molecularly Targeted Cancer Medications and Kidney Health
jamanetwork.com/journals/jam...

www.asn-online.org/education/ki...
Molecularly Targeted Cancer Medications and Kidney Health
This cohort study evaluates the 2-year incidence and relative rates of progressive kidney dysfunction in patients treated with molecularly targeted cancer medications.
jamanetwork.com
November 10, 2025 at 6:28 AM
pablogarciamd.bsky.social
This is the APRIL inhibitors ASN Kidney Week
November 8, 2025 at 6:37 PM
pablogarciamd.bsky.social
🤣🤣
August 11, 2025 at 1:31 AM
pablogarciamd.bsky.social
I saw it in the same spot by CTSC, running away from a coyote 🐺
August 11, 2025 at 1:11 AM
pablogarciamd.bsky.social
In the final score table @glombandit.bsky.social who is an attending, scored higher than @nephrowhitt.bsky.social #NephMadness
April 16, 2025 at 5:51 PM
pablogarciamd.bsky.social
I was about to text you and @hswapnil.medsky.social about it. Terrible situation
March 15, 2025 at 1:51 PM
pablogarciamd.bsky.social
🤣🤣 I think some of those votes on zoom were ignored
March 13, 2025 at 11:54 PM
pablogarciamd.bsky.social
March 13, 2025 at 11:38 PM
pablogarciamd.bsky.social
www.nejm.org/doi/full/10....
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | NEJM
Effective targets for systolic blood-pressure control in patients with type 2 diabetes are unclear. We enrolled patients 50 years of age or older with type 2 diabetes, elevated systolic blood press...
www.nejm.org
November 17, 2024 at 3:59 AM